| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Tyr_Pase_AS | 1.75e-03 | 73 | 16 | 2 | IPR016130 | |
| Domain | - | 2.75e-03 | 92 | 16 | 2 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 3.18e-03 | 99 | 16 | 2 | IPR029021 | |
| Domain | - | 1.51e-02 | 222 | 16 | 2 | 1.25.10.10 | |
| Domain | ARM-like | 2.19e-02 | 270 | 16 | 2 | IPR011989 | |
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 16815646 | ||
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 1.01e-05 | 10 | 17 | 2 | 25605905 | |
| Pubmed | 1.23e-05 | 11 | 17 | 2 | 21705651 | ||
| Pubmed | 2.04e-05 | 14 | 17 | 2 | 19380791 | ||
| Pubmed | 3.05e-05 | 17 | 17 | 2 | 24129162 | ||
| Pubmed | Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors. | 3.42e-05 | 18 | 17 | 2 | 35358427 | |
| Pubmed | Lymphatic Endothelial Cells Control Initiation of Lymph Node Organogenesis. | 3.42e-05 | 18 | 17 | 2 | 28709801 | |
| Pubmed | Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. | 4.25e-05 | 20 | 17 | 2 | 30988302 | |
| Pubmed | YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells. | 5.66e-05 | 23 | 17 | 2 | 31980640 | |
| Pubmed | 5.66e-05 | 23 | 17 | 2 | 12648490 | ||
| Pubmed | Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. | 1.11e-04 | 32 | 17 | 2 | 20056645 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 2.66e-04 | 262 | 17 | 3 | 36880596 | |
| Pubmed | 3.29e-04 | 55 | 17 | 2 | 10926756 | ||
| Pubmed | 4.86e-04 | 322 | 17 | 3 | 26514267 | ||
| Coexpression | WHITFIELD_CELL_CYCLE_G2 | 1.65e-04 | 168 | 17 | 3 | M2076 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 1.70e-04 | 170 | 17 | 3 | M5657 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 1.73e-04 | 171 | 17 | 3 | M5655 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 2.63e-04 | 197 | 17 | 3 | M7543 | |
| Coexpression | GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP | 2.67e-04 | 198 | 17 | 3 | M9803 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP | 2.67e-04 | 198 | 17 | 3 | M8269 | |
| Coexpression | GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 2.71e-04 | 199 | 17 | 3 | M3266 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN | 2.71e-04 | 199 | 17 | 3 | M3907 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 2.71e-04 | 199 | 17 | 3 | M9595 | |
| Coexpression | GSE34006_WT_VS_A2AR_KO_TREG_DN | 2.75e-04 | 200 | 17 | 3 | M9042 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | 2.75e-04 | 200 | 17 | 3 | M9051 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 2.75e-04 | 200 | 17 | 3 | M7320 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_UP | 2.75e-04 | 200 | 17 | 3 | M4851 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 2.75e-04 | 200 | 17 | 3 | M6625 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN | 2.75e-04 | 200 | 17 | 3 | M3823 | |
| Coexpression | DELPUECH_FOXO3_TARGETS_DN | 3.04e-04 | 40 | 17 | 2 | M2314 | |
| Coexpression | QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP | 4.03e-04 | 46 | 17 | 2 | M41048 | |
| Coexpression | QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP | 4.03e-04 | 46 | 17 | 2 | M41047 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.17e-07 | 191 | 17 | 4 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.28e-07 | 198 | 17 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Control-NK_activated|Control / Disease condition and Cell class | 1.19e-05 | 119 | 17 | 3 | 0d0bab03d56e269c6e637b0bbeffe9d1491dfc33 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-05 | 162 | 17 | 3 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.06e-05 | 163 | 17 | 3 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 170 | 17 | 3 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.84e-05 | 176 | 17 | 3 | 1870860a9ebe7a655c4ea8898427e1097ee23113 | |
| ToppCell | ASK428-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.91e-05 | 177 | 17 | 3 | 66074a288501c136b4e83b883db5f0d8269ee326 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 4.04e-05 | 179 | 17 | 3 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 4.11e-05 | 180 | 17 | 3 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-05 | 181 | 17 | 3 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.39e-05 | 184 | 17 | 3 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 4.39e-05 | 184 | 17 | 3 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.39e-05 | 184 | 17 | 3 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.39e-05 | 184 | 17 | 3 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 190 | 17 | 3 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 191 | 17 | 3 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 191 | 17 | 3 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 191 | 17 | 3 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.90e-05 | 191 | 17 | 3 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Macrophage|Liver / Manually curated celltypes from each tissue | 4.90e-05 | 191 | 17 | 3 | bd7fd445e3d6316d0336c109889e7e6dc394a55e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 191 | 17 | 3 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.98e-05 | 192 | 17 | 3 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 192 | 17 | 3 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 192 | 17 | 3 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 5.06e-05 | 193 | 17 | 3 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 193 | 17 | 3 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 193 | 17 | 3 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 193 | 17 | 3 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 5.06e-05 | 193 | 17 | 3 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.13e-05 | 194 | 17 | 3 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 194 | 17 | 3 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.13e-05 | 194 | 17 | 3 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 5.21e-05 | 195 | 17 | 3 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-05 | 195 | 17 | 3 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.21e-05 | 195 | 17 | 3 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-05 | 195 | 17 | 3 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-05 | 195 | 17 | 3 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-05 | 195 | 17 | 3 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 196 | 17 | 3 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 196 | 17 | 3 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 197 | 17 | 3 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.37e-05 | 197 | 17 | 3 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.37e-05 | 197 | 17 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 197 | 17 | 3 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.37e-05 | 197 | 17 | 3 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 5.37e-05 | 197 | 17 | 3 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.45e-05 | 198 | 17 | 3 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.45e-05 | 198 | 17 | 3 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.45e-05 | 198 | 17 | 3 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.45e-05 | 198 | 17 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.45e-05 | 198 | 17 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 5.45e-05 | 198 | 17 | 3 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 5.54e-05 | 199 | 17 | 3 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 5.54e-05 | 199 | 17 | 3 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 199 | 17 | 3 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.62e-05 | 200 | 17 | 3 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.62e-05 | 200 | 17 | 3 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 5.62e-05 | 200 | 17 | 3 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.62e-05 | 200 | 17 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 5.62e-05 | 200 | 17 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 5.62e-05 | 200 | 17 | 3 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 70 | 17 | 2 | 6b706d0b6b7565ba7d6b169c6b49497e510de68b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 70 | 17 | 2 | 8e1c2442e89ed54603905472daa11ec23238ffb0 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.05e-04 | 88 | 17 | 2 | 52d4e572e6800eaa073ef62adaf4e42882ce1eed | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.05e-04 | 88 | 17 | 2 | eadf8f0fb1181c504942c48d55d309ca4e5f6485 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.05e-04 | 88 | 17 | 2 | 72b789cbccce675f37e0553f63df93643af12b4e | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | d102a0a015a2866e3fe549ac8796b9a0d5923d7e | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | 0967a93dcc72d2d8f12d56de186ec1af55c36001 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | 1a112bd4e5e63826efad0338ce99d7a7ad9c72b9 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | 9c566fc2a8c7630bea28e8e46df55454aa409bc1 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | 613c827a643a7b6d70ef932cfa1762e90bc5a338 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.77e-04 | 102 | 17 | 2 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.77e-04 | 102 | 17 | 2 | c58e09aaa11b664c7d99e91f903561fa18460f05 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.77e-04 | 102 | 17 | 2 | 9392288e284b71f3a208d9f283e6e3c944b7dd10 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.77e-04 | 102 | 17 | 2 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.77e-04 | 102 | 17 | 2 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 4b5f545dc02364c5d96a02b0acd68faf1ec4192b | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 927d1071f0719b778f0c3d358c5f96a6ffac6645 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | d5f183263cec9922d23cfd38ce9157eef4e58edb | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 1df80af2c690dac6bfd3dfd7d0052b66c1ae6ea5 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 177414e4c859b047a4644664c596a3c22199cdf2 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 116 | 17 | 2 | e93dd059d272e597a30e93f4c0504636f4e6c899 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease condition and Cell class | 8.74e-04 | 116 | 17 | 2 | e3d1a90a229f5697b2b715574bb96790a435f73b | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 116 | 17 | 2 | d3194bda2e3d5fd021e4015eed98c5888befe03d | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 116 | 17 | 2 | 27201cb805fe73b5ec51d7d585d047a4c043e8b0 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 116 | 17 | 2 | 4e84b6f6661bb5ba0fe0de38a23bee9cc3727d94 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 116 | 17 | 2 | 15d9a3d8c3cc1f6a1aead03cf84dc876c76b7063 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.50e-04 | 121 | 17 | 2 | 4ec70ad316942d9ade7bbdbf0e117e7c52b59d90 | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-03 | 130 | 17 | 2 | 3a0846b74ba34bd0e2a05b4f1f39f3940df93780 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.23e-03 | 138 | 17 | 2 | 8d70e64843f7c3be8ee4203cc126fdf1001f0df5 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-03 | 140 | 17 | 2 | 568a008ff103269e9fe36aa95e9d302641efed98 | |
| ToppCell | Mild/Remission-B_intermediate-14|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.29e-03 | 141 | 17 | 2 | 69e32125a0e8f0c8561e5e7a93607f368f09546f | |
| Disease | eye disease | 2.69e-04 | 45 | 16 | 2 | EFO_0003966 | |
| Disease | Drugs used in diabetes use measurement | 3.29e-04 | 255 | 16 | 3 | EFO_0009924 | |
| Disease | generalised epilepsy | 3.60e-04 | 52 | 16 | 2 | EFO_0005917 | |
| Disease | monocyte percentage of leukocytes | 5.36e-04 | 731 | 16 | 4 | EFO_0007989 | |
| Disease | Corneal astigmatism | 7.88e-04 | 77 | 16 | 2 | EFO_1002040 | |
| Disease | lean body mass | 1.04e-03 | 379 | 16 | 3 | EFO_0004995 | |
| Disease | age at onset, Myopia | 2.94e-03 | 150 | 16 | 2 | EFO_0004847, HP_0000545 | |
| Disease | FEV/FEC ratio | 3.64e-03 | 1228 | 16 | 4 | EFO_0004713 | |
| Disease | Hypermetropia, Myopia | 4.62e-03 | 189 | 16 | 2 | HP_0000540, HP_0000545 | |
| Disease | monocyte count | 4.71e-03 | 1320 | 16 | 4 | EFO_0005091 | |
| Disease | refractive error, age at onset, Myopia | 4.81e-03 | 193 | 16 | 2 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 4.86e-03 | 194 | 16 | 2 | EFO_0004265, EFO_0007908 | |
| Disease | Abnormality of refraction | 5.30e-03 | 673 | 16 | 3 | HP_0000539 | |
| Disease | chronic obstructive pulmonary disease | 5.63e-03 | 688 | 16 | 3 | EFO_0000341 | |
| Disease | eosinophil count | 7.20e-03 | 1488 | 16 | 4 | EFO_0004842 | |
| Disease | forced expiratory volume | 8.22e-03 | 789 | 16 | 3 | EFO_0004314 | |
| Disease | balding measurement | 8.31e-03 | 792 | 16 | 3 | EFO_0007825 | |
| Disease | erythrocyte measurement | 8.37e-03 | 257 | 16 | 2 | EFO_0005047 | |
| Disease | Autistic Disorder | 8.62e-03 | 261 | 16 | 2 | C0004352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQNWNYTVYVVNISF | 441 | Q86SQ4 | |
| QSNYQYITNFEWYIS | 406 | O14617 | |
| QYLWTCTQEYVQSQD | 816 | Q8IXQ6 | |
| FQNNQALTYWECVYL | 331 | Q12791 | |
| SQYQCWDLVQQTQNY | 296 | Q8NCE2 | |
| NCVWNCYKYINNRNV | 181 | Q15012 | |
| NCYQTYLTQFQVINW | 1501 | Q2LD37 | |
| CVKQVQANQEYYQQW | 171 | O15534 | |
| QYQQLCIFWKVNYNF | 601 | P29728 | |
| RQYLDQQQYQSALFW | 11 | Q13042 | |
| GIAQQNNYYCYWQSL | 11 | Q5T4I8 | |
| CQDSESQIQQYQFWQ | 641 | Q96JA4 | |
| LVQYWDQCFYSQEQR | 301 | O43663 | |
| VYNNFLSNSYWSNLN | 121 | Q63HK5 | |
| NSYNEHWNYLTICQL | 86 | P36941 | |
| ASYQDWQQNLYFNCS | 216 | Q9H1Z9 | |
| SWYQILQNYQFTNSE | 186 | O43592 | |
| TVYQYQYTNWSVEQL | 1116 | P08575 |